NeoDynamics presents an abstract on pulse biopsy data for NeoNavia at the UK Association of Breast Surgeons Conference 2021
News provided by
Share this article
Share this article
STOCKHOLM, May 17, 2021 /PRNewswire/ NeoDynamics AB (Spotlight Stock Market: NEOD), a MedTech company dedicated to advancing diagnosis and care of breast cancer, presents pre-clinical data in a poster session at the Association of Breast Surgeons (ABS) online Conference 2021, May 16th – 18th. The data presented in the abstract demonstrates that NeoDynamics FlexiPulse needle outperforms standard core needle biopsy in respect of sample yield in pre-clinical models by almost 300%.
The abstract has been accepted for a poster presentation, titled Novel pulse biopsy platform incorporating adaptive open-tip sampling needle increases sampling yield and needle control , and was co-authored by Prof. Marc Thill, Stefan Paepke, and Kai-Uwe Schässburger.